Antigens induced by the mouse leukemia viruses.
D000406:AKR murine leukemia virus / Q000276:immunology; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000937:Antigen-Antibody Reactions; D000941:Antigens / Q000032:analysis*; D002471:Cell Transformation, Neoplastic; D002859:Chromium Isotopes; D003168:Complement Fixation Tests; D003520:Cyclophosphamide / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D005622:Friend murine leukemia virus / Q000276:immunology; D006413:Hematopoietic System / Q000276:immunology; D007108:Immune Tolerance; D007112:Immunity, Maternally-Acquired; D066298:In Vitro Techniques; D009052:Leukemia Virus, Murine / Q000276:immunology*; D007942:Leukemia, Experimental / Q000209:etiology / Q000276:immunology*; D008325:Mammary Neoplasms, Experimental / Q000276:immunology; D008324:Mammary Tumor Virus, Mouse / Q000276:immunology; D051379:Mice; D008979:Moloney murine leukemia virus / Q000276:immunology; D009368:Neoplasm Transplantation; D011120:Polyomavirus / Q000276:immunology; D011233:Precipitin Tests; D011925:Rauscher Virus / Q000276:immunology; D012190:Retroviridae / Q000145:classification / Q000276:immunology / Q000472:pathogenicity; D012513:Sarcoma, Experimental / Q000139:chemically induced; D012867:Skin / Q000276:immunology; D016038:Skin Transplantation; D012995:Solubility; D013953:Thymus Neoplasms / Q000276:immunology; D014762:Viral Interference
D000906:Antibodies; D000941:Antigens; D002859:Chromium Isotopes; D003520:Cyclophosphamide